Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)
USD 4.0
(0.0%)
USD 4.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.73 Billion USD | -3.76% |
| 2022 | 413.65 Million USD | 18.67% |
| 2021 | 348.58 Million USD | 60.04% |
| 2020 | 217.8 Million USD | 16.49% |
| 2019 | 186.96 Million USD | -81.15% |
| 2018 | 991.74 Million CNY | 36.9% |
| 2017 | 724.42 Million CNY | 62.19% |
| 2016 | 446.66 Million CNY | 5.78% |
| 2015 | 422.25 Million CNY | 42.86% |
| 2014 | 295.56 Million CNY | 94.84% |
| 2013 | 151.69 Million CNY | 22.19% |
| 2012 | 124.14 Million CNY | 34.71% |
| 2011 | 92.16 Million CNY | 55.99% |
| 2010 | 59.08 Million CNY | 144.88% |
| 2009 | 24.12 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 637.23 Million CNY | -3.73% |
| 2024 Q1 | 628.12 Million CNY | 17.22% |
| 2024 Q2 | 661.95 Million CNY | 6.69% |
| 2023 Q2 | 765.56 Million CNY | 639.13% |
| 2023 FY | 398.11 Million USD | -3.76% |
| 2023 Q1 | 103.57 Million USD | 22.19% |
| 2023 Q4 | 568.97 Million CNY | -28.74% |
| 2023 Q3 | 798.47 Million CNY | 4.3% |
| 2022 Q3 | 103.44 Million USD | -85.65% |
| 2022 Q4 | 84.76 Million USD | -18.06% |
| 2022 Q2 | 721.02 Million CNY | 6.86% |
| 2022 Q1 | 674.73 Million CNY | 2.88% |
| 2022 FY | 413.65 Million USD | 18.67% |
| 2021 Q2 | 82.03 Million CNY | 32.38% |
| 2021 FY | 348.58 Million USD | 60.04% |
| 2021 Q3 | 584.85 Million CNY | 612.96% |
| 2021 Q4 | 655.85 Million CNY | 12.14% |
| 2021 Q1 | 61.96 Million CNY | -84.47% |
| 2020 Q2 | 402.95 Million CNY | 34.04% |
| 2020 Q3 | 411.77 Million CNY | 2.19% |
| 2020 Q4 | 398.89 Million CNY | -3.13% |
| 2020 FY | 217.8 Million USD | 16.49% |
| 2020 Q1 | 300.61 Million CNY | -14.19% |
| 2019 Q3 | 316.63 Million CNY | -12.98% |
| 2019 Q4 | 350.33 Million CNY | 10.64% |
| 2019 FY | 186.96 Million USD | -81.15% |
| 2019 Q1 | 272.06 Million CNY | -12.65% |
| 2019 Q2 | 363.86 Million CNY | 33.74% |
| 2018 Q1 | 212.58 Million CNY | -2.38% |
| 2018 FY | 991.74 Million CNY | 36.9% |
| 2018 Q3 | 206.93 Million CNY | -20.64% |
| 2018 Q4 | 311.48 Million CNY | 50.53% |
| 2018 Q2 | 260.74 Million CNY | 22.65% |
| 2017 Q3 | 185.95 Million CNY | 10.29% |
| 2017 FY | 724.42 Million CNY | 62.19% |
| 2017 Q4 | 217.77 Million CNY | 17.12% |
| 2017 Q2 | 168.6 Million CNY | 10.85% |
| 2017 Q1 | 152.09 Million CNY | 52.52% |
| 2016 Q1 | 120.24 Million CNY | 5.46% |
| 2016 Q2 | 114.72 Million CNY | -4.59% |
| 2016 FY | 446.66 Million CNY | 5.78% |
| 2016 Q4 | 99.72 Million CNY | -10.95% |
| 2016 Q3 | 111.97 Million CNY | -2.39% |
| 2015 Q2 | 103.74 Million CNY | 5.26% |
| 2015 Q3 | 105.92 Million CNY | 2.1% |
| 2015 Q4 | 114.01 Million CNY | 7.64% |
| 2015 Q1 | 98.56 Million CNY | 5.32% |
| 2015 FY | 422.25 Million CNY | 42.86% |
| 2014 Q2 | 59.1 Million CNY | 3.74% |
| 2014 Q1 | 56.97 Million CNY | 38.89% |
| 2014 FY | 295.56 Million CNY | 94.84% |
| 2014 Q4 | 93.58 Million CNY | 8.96% |
| 2014 Q3 | 85.89 Million CNY | 45.31% |
| 2013 FY | 151.69 Million CNY | 22.19% |
| 2013 Q1 | 35.92 Million CNY | 6.08% |
| 2013 Q3 | 34.43 Million CNY | -14.59% |
| 2013 Q4 | 41.02 Million CNY | 19.15% |
| 2013 Q2 | 40.31 Million CNY | 12.2% |
| 2012 Q1 | 26.96 Million CNY | 16.64% |
| 2012 Q3 | 32.59 Million CNY | 6.08% |
| 2012 Q4 | 33.87 Million CNY | 3.93% |
| 2012 FY | 124.14 Million CNY | 34.71% |
| 2012 Q2 | 30.72 Million CNY | 13.94% |
| 2011 Q3 | 23.22 Million CNY | 0.0% |
| 2011 Q4 | 23.11 Million CNY | -0.45% |
| 2011 FY | 92.16 Million CNY | 55.99% |
| 2010 FY | 59.08 Million CNY | 144.88% |
| 2009 FY | 24.12 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 3492302.537% |
| Arrayit Corporation | 2.57 Million USD | -261639.77% |
| Atlantic International Corp. | -154.23 Thousand USD | 4370051.435% |
| Biocept, Inc. | -2.58 Million USD | 261136.053% |
| Bioqual, Inc. | 7.42 Million USD | -90623.25% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -2441911.194% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -375576.021% |
| iMD Companies, Inc. | -23.63 Thousand USD | 28514509.172% |
| IDenta Corp. | 662.97 Thousand USD | -1016522.18% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -29149.451% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -8688650.817% |
| InVitro International | 635.98 Thousand USD | -1059665.701% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -102596.189% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -616725.257% |
| NovelStem International Corp. | 12 Thousand USD | -56166157.467% |
| Optigenex Inc. | -102.96 Thousand USD | 6545902.397% |
| PharmChem, Inc. | 3.9 Million USD | -172525.559% |
| Proteome Sciences plc | 2.09 Million USD | -321365.766% |
| Response Genetics, Inc | 3.94 Million USD | -170877.953% |
| Rennova Health, Inc. | 6.26 Million USD | -107425.223% |
| RushNet, Inc. | 1.1 Million USD | -610062.898% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -786749.811% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1669450.087% |
| Todos Medical Ltd. | 4.31 Million USD | -156279.371% |